Hypertrophic cardiomyopathy ß-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super-relaxed state
Alison Schroer Vander Roest(University of Michigan), Daniel Bernstein(Stanford University), Arnav Jhingran(Stanford University), Sara Ranjbarvaziri(Unknown), Kenneth S. Campbell(University of Kentucky), Gwanghyun Jung(Cedars-Sinai Medical Center), James A. Spudich(Stanford University), Beth L. Pruitt(University of California, Santa Barbara), Kristina B. Kooiker(California Institute for Regenerative Medicine), Mingming Zhao(Peking University), Giovanni Fajardo(Cedars-Sinai Medical Center), Gaspard Pardon(Cardiovascular Institute of the South), Makenna M. Morck(Cardiovascular Institute of the South), Dan Song(Stanford University), Kathleen M. Ruppel(Stanford University), Aminah Dawood(Cardiovascular Institute of the South), Chao Liu(Stanford Medicine)
Cited by 4
Related Papers
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
|Science|2016|710
Genomic analyses implicate noncoding de novo variants in congenital heart disease
|Nature Genetics|2020|178
Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes
|Journal of Molecular and Cellular Cardiology|2016|152